Marico Ltd. Share Price

Overview

Marico Ltd. share price is currently ₹908.27, down by - ₹0.52 (0.06%) from its previous closing price of ₹908.79. The share price has gained 19.14% over the past month and gained 23.57% over the past year. The stock's 52-week low and high are ₹697.35 and ₹918.69, respectively. Marico Ltd. has a market capitalisation of ₹ 1,19,311.18 Cr. The share price was last updated on 20 Nov 2026, 03:53 PM IST.

Marico Ltd.
Marico Ltd.
MARICO
 ₹0.00
- ₹0.52
0.06%
FMCG
 ₹0.00(%)1D

Updated: 20 Nov 2026, 03:53:03 pm IST

Market Data

Open Price

 ₹909.81

Prev. Close

 ₹908.79
 ₹902.52

Day Low

 ₹915.37

Day High

 ₹697.35

52 Week Low

 ₹918.69

52 Week High

FMCGEdible Oil
CategoryLarge Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

58.52

Sector PE

31.76

PB Ratio

28.68

Sector PB

7.38

EPS

15.52

Dividend Yield

0.54

Today's Volume

1.671 M

5 Day Avg. Volume

1.975 M

PEG Ratio

7.98

Market Cap.

₹ 1,19,311.18 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 400% at ₹4/Share
30-Jul-202630-Jul-2026
DividendsFinal Dividend of 700% at ₹7/Share
01-Aug-202501-Aug-2025
DividendsInterim Dividend of 350% at ₹3.5/Share
07-Feb-202507-Feb-2025

Mutual Fund Ownership

Mutual Fund Holder
Sep 26
Shares held
Oct 26
Shares held
HDFC Mid Cap Fund - Regular Plan - Growth3.07 Cr
3.20 Cr
(4.17%)
Axis Midcap Fund - Regular Plan - Growth67.51 Lac
70.76 Lac
(4.82%)
Edelweiss Mid Cap Fund - Regular Plan - Growth47.02 Lac
48.26 Lac
(2.63%)
Franklin India Flexi Cap Fund - Growth48.01 Lac
48.01 Lac
no change
Sundaram Mid Cap Fund - Regular Plan - Growth33.00 Lac
33.50 Lac
(1.52%)

About Marico Ltd. 👋

Marico Limited is an India-based consumer goods company operating in the global beauty and wellness categories. The Company operates in product categories such as Coconut Oil, Refined Edible Oils, Value Added Hair Oils, Leave-in Hair Conditioners, Male Grooming and Packaged Foods, among others. Its product portfolio caters to a diverse range of consumer needs and preferences, ranging from hair nourishment and styling to nutrition, immunity, and healthy snacking. The Company manufactures and markets products under the brands such as Parachute, Saffola, Saffola FITTIFY, Hair & Care, Parachute Advansed, Nihar Naturals, Mediker, Pure Sense, Coco Soul, Revive, Set Wet, Livon, Beardo, Just Herbs, True Elements and Plix. The Company's international product portfolio includes brands, such as Parachute, Parachute Advansed, HairCode, Fiancee, Purite de Provence, oliv, Caivil, Hercules, Black Chic, Code 10, Ingwe, X-Men, Thuan Phat and IsoPlus.

Analyst Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Lovelesh Sharma

Lovelesh Sharma

19 Nov • 12:57 PM · SEBI-Registered Analyst

Marico - Fresh Chart High Tests ₹915 Breakout

MARICO ,Marico has pushed to a fresh high within the displayed daily chart, trading near ₹915.50 after a sharp recovery from the recent correction. The broader structure remains constructive, with successive advances carrying price above the previous swing-high region around ₹875–885. The latest candle is trading at its displayed session high, suggesting buying interest remains active. However, the session is still developing, so a closing breakout and subsequent ability to hold above the previous peak would provide stronger confirmation. The 75-period Z-score has risen to 1.97, close to the +2 threshold. This reflects strong positive price deviation from its recent mean, while also showing that the advance is becoming stretched. A pause or pullback would therefore be compatible with the broader uptrend. The immediate reference is the ₹900–905 area, followed by the prior breakout region around ₹875–885. Holding that former resistance as support would keep the structure favourable. A sustained move above the latest high would extend price discovery; a close back below the prior peak would raise the possibility of a failed breakout. Watch how price consolidates after the sharp rise before assuming further follow-through.

See More
CA Sumit Mangla

CA Sumit Mangla

17 Nov • 8:31 AM · SEBI-Registered Analyst

Jefferies Buy on Patanjali Foods; TP ₹550

PATANJALI Jefferies has given a Buy rating on Patanjali Foods with a target price of ₹550. The brokerage expects stronger performance in 2HFY27, driven by volume recovery along with improving margins in the edible oil, foods and FMCG segments. Jefferies forecasts 10% revenue CAGR and 21% PAT CAGR over FY26–29. The positive view is supported by anticipated recovery in volumes and better profitability across key business verticals. Key triggers are the Buy rating with ₹550 target and the expectation of stronger 2HFY27 on volume recovery and margin improvement in edible oil, foods and FMCG. The 10% revenue and 21% PAT CAGR forecast over FY26–29 provides medium-term growth visibility. Peers such as Marico, Emami and Dabur may face comparison on FMCG and edible oil margin trends. Near-term prices could react positively to the brokerage upgrade and growth outlook. Risks include slower-than-expected volume recovery, volatility in edible oil prices or competitive intensity in FMCG. Competitors listed: Marico, Emami, Dabur. We have no financial interest in this news

See More
CA Abhay Varn

CA Abhay Varn

15 Nov • 10:44 PM · SEBI-Registered Analyst

**Title** Patanjali Foods Q2 revenue grows to ₹113.2 bn.

Patanjali Foods Limited PATANJALI reported Q2 standalone revenue of ₹113.2 billion, up from ₹97.99 billion year-on-year. Net profit stood at ₹4.2 billion against ₹5.2 billion earlier. EBITDA declined to ₹4.26 billion from ₹5.5 billion. Margin contracted to 3.76 percent from 5.63 percent. Revenue grew while profitability came under pressure. The results reflect higher sales with lower operating efficiency in the FMCG segment. Key numbers are Q2 revenue of ₹113.2 billion, profit of ₹4.2 billion and margin at 3.76 percent. The revenue growth may support interest while the profit drop could limit upside. Peers such as Hindustan Unilever, Dabur India and Marico could face relative comparison on margins. Risks include continued cost pressure or weaker demand. Competitors listed: Hindustan Unilever, Dabur India, Marico. We have no financial interest in this news.

See More
Vimal K

Vimal K

10 Nov • 5:58 PM · SEBI-Registered Analyst

NIFTY FMCG Index Daily Chart Technical Analysis

The Nifty FMCG Index (CMP: 46,660.65) is showing early signs of a structural trend reversal on the daily timeframes. After a massive 20% correction throughout 2026 driven by climbing raw material costs (palm oil, packaging, sugar) and a weak rupee, the defensive heavyweights are finally carving out a clear accumulation base. Nifty FMCG is still below the 200 Day Exponential Moving Average and just above the 100 Day Exponential Moving Average. Thus 200 Day Exponential Moving Average around 48450 to 48500 levels will act as the immideate resistence and 100 Day Exponential Moving Average will act as the immideate support and levels to watch will be around 46000 to 45900. It is comfotably trading above its short term and medium term Exponential Moving Average of 20 Day and 50 Day. Macd Histogram above zero indicates a bullish trend and RSI above 60 also indicates a bullish trend and has enough headroom for upside momentum. It has given a break out above the trendline on Daily charts and is countinuing to hold above the break out levels. The top-performing fast-moving consumer goods (FMCG) stocks leading the index recovery include NESTLEIND, MARICO, PATANJALI. NESTLEIND

See More
Deepak Pal

Deepak Pal

9 Nov • 3:58 PM · SEBI-Registered Analyst

MARICO: A BIGGER BET ON INDIA'S FAST-GROWING WELLNESS MARKET

An additional ₹113.65 crore investment takes ownership to 80% — but the bigger opportunity could lie in the business's growth over the next few years. Marico is strengthening its presence in India's rapidly expanding functional wellness and nutrition market. The company has acquired an additional 20% stake in Cosmix Wellness Private Limited for ₹113.65 crore, increasing its total shareholding from 60% to 80%. The transaction gives Marico greater ownership of a digital-first wellness brand operating in categories such as plant-based protein, functional nutrition and superfood blends. Interestingly, this may not be the final step. Marico also has the option to acquire the remaining 20% stake after FY29, subject to the achievement of specified milestones, requisite approvals and agreed conditions. Let's understand why this acquisition matters and what investors should watch. 1. THE DEAL: MARICO INCREASES OWNERSHIP TO 80% Marico completed the acquisition of an additional 20% stake in Cosmix Wellness on 6 November 2026. Key transaction details Particulars Details Company acquired Cosmix Wellness Pvt. Ltd. Additional stake acquired 20% Previous shareholding 60% New shareholding 80% Acquisition consideration ₹113.65 crore Mode of payment Cash Completion date 6 November 2026 Remaining stake 20% Future acquisition option After FY29, subject to milestones --->Why is this segment important? Indian consumers are increasingly exploring alternatives to conventional nutrition products, including plant-based protein, gut-friendly formulations and functional foods. 3. COSMIX REVENUE GROWTH: THE NUMBERS ARE INTERESTING One of the most important aspects of this acquisition is the growth in Cosmix's reported turnover. Financial year Turnover FY24 ₹24.32 crore FY25 ₹47.25 crore FY26 ₹91.53 crore

See More
Finkhoz Roboadvisory Services

Finkhoz Roboadvisory Services

9 Nov • 8:23 AM · SEBI-Registered Analyst

Marico raises Cosmix stake to 80%, buys into Bonorizon

MARICO Limited (MARICO) is in focus on November 9 after announcing two deals worth about ₹149 crore. It bought a further 20% of plant-based protein brand Cosmix Wellness for ₹114 crore, taking its holding to 80%. It also agreed to acquire 51% of Bonorizon Consumer Ventures for up to ₹35 crore. Both deals were disclosed after market hours on Friday, November 6. The Bonorizon stake will come through a primary subscription, all in cash, and is expected to close within 90 days. Marico can buy the remaining stake after three years, at a price to be decided then. It links the deal to its plans for international business and digital growth in overseas markets. The deals fit Marico’s strategy of building a portfolio of digital-first brands in health and wellness. Cosmix sells plant-based protein and superfood supplements, a fast-growing category, and taking majority control lets Marico scale it faster. The combined ₹149 crore outlay is small relative to Marico’s quarterly revenue of about ₹3,900 crore. The price for Cosmix has risen sharply. Marico first bought 60% at an equity valuation of ₹375 crore. The latest 20% for ₹114 crore implies a valuation of about ₹570 crore, roughly 52% higher. Details on Bonorizon’s business and financials are thin, and both deals include options to buy the remaining stakes later, at prices not yet fixed. Investors should watch Cosmix’s revenue growth and profitability, details on Bonorizon’s business, and the cost of buying the remaining stakes. The key question is whether these digital brands can grow fast enough to justify the rising valuations Marico is paying. Disclosure: I do not hold any position in Marico Limited. This post is for informational purposes only and is not investment advice.

See More

News & Events

Frequently Asked Questions

What is the share price of Marico Ltd.?

What is the market cap of Marico Ltd.?

Should I buy Marico Ltd. stock now?

What is the 52 week high and low of Marico Ltd.?

Is the Marico Ltd. stock good to buy?

Is Marico Ltd. a good buy for the long term?

Is Marico Ltd. overvalued or undervalued?

What is the PE and PB ratio of Marico Ltd.?

Start Now